Polypeptide that specifically binds to β-catenin protein with high affinity and its application and synthesis method
An affinity and specific technology, applied in the direction of peptide/protein components, medical preparations containing active ingredients, peptides, etc., can solve the problem of lack of polypeptide β-catenin and BCL9, and achieve the induction of cell self-apoptosis and high yield efficiency. , the effect of inhibiting tumor growth
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments.
[0020] The invention discloses a polypeptide specifically binding to β-catenin protein with high affinity. The amino acid sequence of the polypeptide is LEHRERSLQT(X1)RDIQRML(X2)P, wherein X1 is leucine (L), norleucine (NLE ) or homoleucine (HLE); X2 is phenylalanine (F), 1-naphthylalanine (1-NAL), 2-naphthylalanine (2-NAL), 2-anthracenyl Alanine (2-Anla) or 9-Anthracenylalanine (9-Anla).
[0021] The invention also discloses the application of a polypeptide that specifically binds to β-catenin protein with high affinity for inhibiting the growth of cancer cells, specifically for inhibiting the β-catenin / Wnt signaling pathway of cancer cells, inhibiting tumor growth, and inducing cell Self-apoptosis, more specifically, is used to inhibit the mutual binding of β-catenin and BCL9 in cancer cells, thereby inhibiting the β-catenin / Wnt signaling ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap